Iznardo, H, Puig, L. Dual inhibition of IL-17A and IL-17F in psoriatic disease. Therapeutic Advances in Chronic Disease. 2021; 12DOI:10.1177/20406223211037846. PMID:34408825. IF:4.970(Q2/3D).

Speeckaert, R, Lambert, J, Puig, L, Speeckaert, M, Lapeere, H, De Schepper, S, van Geel, N. Comment on "An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology''. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2021; 85(2)DOI:10.1016/j.jaad.2021.03.038. PMID:33744352. IF:15.487(Q1/1D).

van Straalen, KR, Tzellos, T, Guillem, P, Benhadou, F, Cuenca-Barrales, C, Daxhelet, M, Daoud, M, Efthymiou, O, Giamarellos-Bourboulis, EJ, Jemec, GBE, Katoulis, AC, Koenig, A, Lazaridou, E, Marzano, AV, Matusiak, L, Molina-Leyva, A, Moltrasio, C, Pinter, A, Potenza, C, Romani, J, Saunte, DM, Skroza, N, Stergianou, D, Szepietowski, J, Trigoni, A, Vilarrasa, E, van der Zee, HH. The efficacy and tolerability of tetracyclines and clindamycin plus rifampicin for the treatment of hidradenitis suppurativa: Results of a prospective European cohort study. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2021; 85(2)DOI:10.1016/j.jaad.2020.12.089. PMID:33484766. IF:15.487(Q1/1D).

Puig, L, Bakulev, AL, Kokhan, MM, Samtsov, AV, Khairutdinov, VR, Morozova, MA, Zolkin, NA, Kuryshev, IV, Petrov, AN, Artemeva, AV, Zinkina-Orikhan, AV. Efficacy and Safety of Netakimab, A Novel Anti-IL-17 Monoclonal Antibody, in Patients with Moderate to Severe Plaque Psoriasis. Results of A 54-Week Randomized Double-Blind Placebo-Controlled PLANETA Clinical Trial. Dermatology and Therapy. 2021; 11(4)DOI:10.1007/s13555-021-00554-4. PMID:34060012. IF:3.661(Q2/3D).